Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)

NCT07266545 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07266545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07266545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Recruiting
Start date
February 17, 2026
Completion date
December 31, 2030
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, unipolar depression